PA

Pangaea Asset Management

North America, Illinois, United States, Chicago

Description

A specialized asset management firm based in Chicago.

Investor Profile

Pangaea Asset Management has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Oncology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pangaea Asset Management frequently co-invest with?

ProQuest Investments
North America, New Jersey, United States, Princeton
Co-Investments: 1
LG
North America, Texas, United States, Dallas
Co-Investments: 1
Henderson Global Investors
Europe, England, United Kingdom, London
Co-Investments: 1
Paramount BioCapital Asset Management
North America, New York, United States, New York
Co-Investments: 1
Cycad Group
North America, California, United States, Santa Barbara
Co-Investments: 1
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Pangaea Asset Management?

Alaunos Therapeutics

New York, New York, United States

Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.

BiotechnologyGeneticsOncologyPharmaceuticalTherapeutics
Post Ipo EquityMay 3, 2006
Amount Raised: $37,000,000